Treatment of Limited Small Cell Lung Cancer with Concurrent Chemotherapy, Radiotherapy, With or Without GM-CSF and Subsequent Randomization to Maintenance Interferon or No Maintenance

Value of Anti-Cancer Drugs in SWOG Phase III Clinical Trials: Evidence from Multiple Evaluation Mechanisms

V Nghiem;R Vaidya;M Banegas;D Hershman;J Unger AcademyHealth Annual Research Meeting (June 23-26, 2018, Seattle, WA), poster #B-335

Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328

KS Albain;JM Unger;JJ Crowley;CA Coltman;DL Hershman Journal of the National Cancer Institute 101(14):984-992

Minority report: how best to analyze clinical trial data to address disparities

D Hershman;J Unger Breast Cancer Research and Treatment 118:519-521

The Southwest Oncology Group: progress in cancer research [PMID18929152]

CA Coltman Seminars in Oncology 35(5):545-552

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: A prospective phase III randomized study of the Southwest Oncology Group.

PA Bunn;J Crowley;K Kelly;MB Hazuka;K Beasley;C Upchurch;GR Weiss;WJ Hicks;DR Gandara;S Rivkin;R Livingston Journal of Clinical Oncology 13(7):1632-1641

Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: A Southwest Oncology Group study.

K Kelly;JJ Crowley;PA Bunn Jr;MB Hazuka;K Beasley;C Upchurch;GR Weiss;WJ Hicks;DR Gandara;S Rivkin;RB Livingston Journal of Clinical Oncology 13(12):2924-2930

The role of alpha interferon (rINFa2a) maintenance in patients with limited stage SCLC responding to con-current chemoradiation: A Southwest Oncology Group study.

K Kelly;PA Bunn Jr;M Hazuka;K Beasley;J Crowley;R Livingston ASCO 12:330(#1099)

The role of GM-CSF in limited stage SCLC: A randomized phase III study of the Southwest Oncology Group (SWOG).

PA Bunn;J Crowley;M Hazuka;R Tolley;R Livingston ASCO 11:292(#974)